Concepedia

Giulio Bontempi

GB

4

Publications

59

Citations

4

H-Index

2022

Active since

Affiliations

Sapienza University of Rome(Current)

Istituto Pasteur

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Giulio Bontempi is an author at Sapienza University of Rome specializing in medicine, pharmacology, and tumor biology.

ORCID

Top concepts

Publications per year

2022–2024

4

Publications

4

Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells

Giulio Bontempi, Michela Terri, Sabrina Garbo et al. · Cell Death and Disease · 2022 · 19 citations · Full text

Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells

Elisabetta Di Bello, Veronica Sian, Giulio Bontempi et al. · European Journal of Medicinal Chemistry · 2022 · 17 citations · Full text

, , +13

HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling

Michela Terri, Pilar Sandoval, Giulio Bontempi et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 13 citations · Full text

HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells

Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi et al. · Frontiers in Cellular and Infection Microbiology · 2023 · 10 citations · Full text

Rows per page

1–4 of 4